You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
人福醫藥(600079.SH):大股東簽署表決權委託協議
格隆匯 11-29 18:27

格隆匯11月29日丨人福醫藥(600079.SH)公佈,為進一步支持公司的健康發展,保持公司的經營穩定,促進公司可持續發展,宜昌產投集團與李傑、陳小清及徐華斌於2024年11月29日簽署《表決權委託協議》及《表決權委託協議之補充協議》,李傑、陳小清及徐華斌將其持有的141,768,007股公司股份(佔公司總股本的8.69%,其中包括李傑先生持有的86,747,204股、陳小清先生持有的43,000,087股以及徐華斌先生持有的12,020,716股)對應的表決權不可撤銷、排他及唯一地委託給宜昌產投集團行使,表決權委託期限自《表決權委託協議》簽署之日起三年。

本次權益變動前,李傑先生持有公司股份86,747,204股,佔公司總股本的5.31%,擁有表決權的股份86,747,204股,佔公司總股本的5.31%;陳小清先生持有公司股份43,000,087股,佔公司總股本的2.63%,擁有表決權的股份43,000,087股,佔公司總股本的2.63%;徐華斌先生持有公司股份12,020,716股,佔公司總股本的0.74%,擁有表決權的股份12,020,716股,佔公司總股本的0.74%。宜昌產投集團未持有公司股份。

本次權益變動後,李傑先生持有無表決權的公司股份86,747,204股,佔公司總股本的5.31%;陳小清先生持有無表決權的公司股份43,000,087股,佔公司總股本的2.63%;徐華斌先生持有無表決權的公司股份12,020,716股,佔公司總股本的0.74%。宜昌產投集團未持有公司股份,行使合計141,768,007股股份對應的表決權,佔公司總股本的8.69%。

本次協議的簽署不會導致上市公司控制權發生變更,亦未觸發《上市公司收購管理辦法》規定的要約收購。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account